Global Echotherapy Market, by Application (Neurological Disorders, Prostate Cancer, Uterine Fibroids, Other Applications), By End-Use (Hospitals, Diagnostic Centers, Research Centers), and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Echotherapy Market Overview:

The global echotherapy market is projected to reach USD 1,967.15 Mn by 2031 at a CAGR of 7.00%, from USD 1,000.00 Mn in 2021.

“Global Echotherapy Market, by Application (Neurological Disorders, Prostate Cancer, Uterine Fibroids, Other Applications), By End-Use (Hospitals, Diagnostic Centers, Research Centers), and by Region – Global Forecast to 2031”. This report offers a holistic view of the global echotherapy market through systematic segmentation that covers every aspect of this target market.

In healthcare, many treatments are used to help people get better. Echotherapy is a therapy that uses sound waves to treat medical conditions. It treats various medical conditions, including cancer, pain, and depression. Echotherapy is a non-invasive treatment and does not require surgery. Echotherapy is a relatively new treatment that uses sound waves to relieve pain. The use of sound waves for healing is not a new concept. It has been used for centuries in various forms, such as singing bowls, gongs, and tuning forks. More recently, it has been used in the form of echotherapy. Echotherapy uses sound waves to direct energy and vibration to specific body areas. This can help to restore balance and promote healing. The therapy is non-invasive and does not use drugs or surgery. It is said to be beneficial for arthritis, carpal tunnel syndrome, and chronic pain. These vibrations also help to increase blood flow and promote healing. Echotherapy is a form of sound therapy that uses the pulses of ultrasound waves to help relieve pain and promote healing. The ultrasonic waves create heat that helps reduce inflammation and break up scar tissue. Echotherapy can be used to treat a variety of conditions, including chronic pain, sports injuries, and post-surgery rehabilitation. Certain people also find that it helps them relax and sleep better. Prostate cancer is now commonly treated with echotherapy, which uses high-frequency ultrasound waves. Because of its good treatment margins, non-invasiveness, and low complication rates, echotherapy is widely employed in interventional oncology. There is some scientific evidence to support these claims. However, more research is needed to determine the full extent of echotherapy’s benefits.

Global Echotherapy Market Revenue (US$ Mn), 2021–2031

Source: Prudour, 2021

The global echotherapy market is primarily propelled by the increasing prevalence of cancer globally, higher public-private expenditures, and the preference for minimally invasive treatment procedures. Furthermore, the worldwide echotherapy market has been fueled by expanding breakthroughs in medical technology and its wide variety of applications in treating neurological illnesses and uterine fibroids. Moreover, over the forecast period, emerging applications such as neurosurgery, urinary disease imaging, gynecology & obstetrics, and the removal or reduction of excess subcutaneous fatty tissue from the body utilizing high-frequency sound waves will move the global echotherapy market forward. Moreover, the growing prevalence of diseases such as pancreatic cancer, primary and secondary liver cancer, prostate cancer, bladder cancer, and kidney cancer are fueling the expansion of the echotherapy industry. According to the American Cancer Society, the United States had around 161,360 new recorded cases of prostate cancer in 2016. Evolving medical technology and its applications in treating neurological disorders, uterine fibroids, and other disorders have fueled the echotherapy market’s revenue growth. Over the projected timeline, the echotherapy market is expected to benefit from increased innovation in sophisticated technology and other therapeutics such as robotic surgery, drug/gene delivery, and molecular imaging. These are certain factors that will help augment this market in the years to come.

However, tedious reimbursement conditions, stringent rules for the approval of new technologies, and increasing price pressures are all limiting factors for the echotherapy market’s economic growth. Furthermore, a shortage of personnel to manage modern technology in specific locations, particularly in developing countries, and an absence of knowledge about disease diagnosis and treatment, are expected to hamper the global echotherapy market’s expansion prospects.

The global echotherapy market is very competitive and looks too fragmented, owing to numerous small and large-scale companies worldwide. To acquire an advantage over their competitors and thus maintain their market position, established market players employ various business tactics such as acquisitions, collaborations, partnerships, expansions, product introductions, and securing FDA approvals.

For example, in February 2019, HIFU Prostate Services LLC (United States), a leading provider of echotherapy equipment to physicians around the country, announced cooperation with Urology Associates, P.C. (United States), one of the country’s leading private urology institutions. As a result of this relationship, the company will be able to market its present echotherapy programmer and provide support to patients seeking echotherapy as a prostate cancer treatment.

Due to numerous factors such as the increasing prevalence of chronic diseases such as cancer, favorable regulatory scenarios connected with echotherapy, and booming geriatric populations, the echotherapy market in the Asia-Pacific is expected to expand significantly shortly. Furthermore, suppliers’ increased focus on emerging countries such as China and India will likely drive this region’s echotherapy market growth prospects. Over the projected timeline, China and India will present lucrative growth prospects for market participants. Additionally, increased R&D investments, increased disease diagnosis awareness, and the growing presence of vital regional businesses are expected to enhance the expansion of echotherapy. For instance, THERACLION, a leading medical equipment provider for echotherapy, announced in June 2017 that its long-term partner, the University of Virginia (UVA), had received FDA approvals to conduct a new clinical study combining pembrolizumab, a modern immunotherapy drug targeting PD-1 checkpoint inhibitor, with echotherapy.

The Global Echotherapy Market Segmentation

Based on, Application, End-Use, and Region

Based on Application

• Neurological Disorders
• Prostate Cancer
• Uterine Fibroids
• Other Applications

Based on End-Use

• Hospitals
• Diagnostic Centers
• Research Centers

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

The research report on the global echotherapy market includes major company profiles such as

• Image-Guided Therapy
• EDAP TMS
• Theraclion
• SonaCare Medical LLC
• Chongqing Haifu Medical Technology Co. Ltd.
• Shanghai A&S Co. Ltd.
• Koninklijke Philips N.V.
• FUS Instruments Inc.
• Insightec Ltd.
• Alpinion Medical Systems, among others.

For the Echotherapy Market research study, the following years have been considered to estimate the market size: